ARCHIVES

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

This article is from The Cancer Letter archive.

Vol. 19 No. 07 | February 12, 1993

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says

December 9, 1983

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

RG7204 Meets Endpoints Of Extending Survival, PFS

February 25, 2011